A Study of 2 Doses of MAP0010 in Adult Asthmatics (P202)
This study has been completed.
Sponsor:
MAP Pharmaceuticals, Inc.
Information provided by:
MAP Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00554970
First received: October 30, 2007
Last updated: January 23, 2009
Last verified: January 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2008 |
| Primary Completion Date: | January 2008 (Final data collection date for primary outcome measure) |